Mimedx (MDXG) EBT Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EBT Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 17.92% |
| 10 | Mimedx | 676.17 Mn | 540.33 Mn | 44.38 Mn | -57.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.91% |
| Mar 31, 2026 | -100.89% |
| Dec 31, 2025 | 30.27% |
| Sep 30, 2025 | 67.85% |
| Jun 30, 2025 | 47.42% |
| Mar 31, 2025 | 41.38% |
| Dec 31, 2024 | 398.15% |
| Sep 30, 2024 | 96.64% |
| Jun 30, 2024 | 146.69% |
| Mar 31, 2024 | 49.94% |
| Dec 31, 2023 | 40.79% |
| Sep 30, 2023 | 35.48% |
| Jun 30, 2023 | 45.61% |
| Mar 31, 2023 | 51.05% |
| Dec 31, 2022 | 49.76% |
| Sep 30, 2022 | -39.14% |
| Jun 30, 2022 | 14.30% |
| Mar 31, 2022 | 7.63% |
| Dec 31, 2021 | 26.21% |
| Sep 30, 2021 | -84.87% |